Islets proteomics demonstrated that DFEs in the OI vs. STZ groups were significantly enriched in diabetes, insulin secretion, insulin resistance, and in the HIF1-α, mTOR, and MAPK signaling pathways (Fig. 2F). The gene discussed is MTOR; the disease is diabetes mellitus.